Mexico's SMSP public health institute ready for greater influence
This article was originally published in Clinica
Pablo Kuri Morales began his tenure as president of Mexico's public health institute, Sociedad Mexicana de Salud Pública, with the unveiling last week of its 2009-10 work plan. Its main aim is to strengthen its policy-generating influence and role as interlocutor between public health players (the document is available at: www.smsp.org.mx). The SMSP is a long-standing and influential non-governmental preventive healthcare policy body that ostensibly focuses on the under-covered segments of the population. Dr Kuri's medical and healthcare policy career has specialised in surgery (he is member of the national surgery academy) and epidemiological surveillance.
You may also be interested in...
UK start-up Iceni Diagnostics has secured funding to develop its test for the live, intact SARS-CoV-2 virus and the UK government is evaluating a lateral flow device based on the technology for testing saliva samples as part of efforts to step up rapid testing in the country. See what Iceni’s CEO Rob Field said about it here.
The run-away US FDA advisory committee review of Biogen’s Alzheimer’s candidate was highly unusual. But like most things at the agency, not entirely unprecedented.
Trump Administration’s attempt to eliminate rebates in the US Medicare outpatient drug benefit program is the easiest and most certain item among the 11th hour pricing policy changes for the incoming Biden Administration to undo. But it still had a major impact on the dynamics of the drug pricing debate.